| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 182,755 | 112,396 | 52,183 | | Cost of Revenue | 130,882 | 80,363 | 52,700 | | | Gross Profit | 51,873 | 32,033 | (517) | | | Operating Expenses | | Research Development | 19,675 | 15,651 | 17,453 | | Selling General and Administrative | 37,516 | 28,752 | 17,894 | | Non Recurring | 1,030 | 7,462 | 667 | | Others | 1,848 | 5,058 |
-
| | | | Total Operating Expenses | 60,069 | 56,923 |
-
| | | | Operating Income or Loss | (8,196) | (24,890) | (36,532) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 296 | 2,323 | 1,755 | | Earnings Before Interest And Taxes | (7,900) | (22,567) | (34,777) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (7,900) | (22,567) | (34,777) | | Income Tax Expense | 8,735 | 2,880 | (101) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,635) | (25,447) | (34,675) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (16,635) | (25,447) | (34,675) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,635) | ($25,447) | ($34,675) |
|
1.48% Nasdaq 
Income Statement
